Stereochemistry
Stereochemistry is the study of the three-dimensional arrangement of atoms in molecules and how this affects their chemical and biological properties. It is crucial in pharmaceuticals, where different stereoisomers can exhibit distinct pharmacological activities.
What is stereochemistry?
Stereochemistry examines the spatial orientation of atoms within molecules, particularly focusing on stereoisomers—compounds with identical molecular formulas and connectivity but different spatial arrangements. This includes enantiomers (mirror-image isomers) and diastereomers (non-mirror-image isomers). The biological activity of a molecule often depends on its stereochemistry; for example, one enantiomer of a drug may be therapeutically active while the other could be inactive or even toxic.
Why does stereochemistry matter in drug development?
In pharmaceuticals, stereochemistry is critical because biological systems are inherently chiral. Enzymes, receptors, and other biomolecules interact with drugs in a stereoselective manner. Regulatory agencies such as the MHRA, EMA, and FDA require detailed stereochemical characterisation of chiral drugs. This includes establishing the absolute configuration, ensuring enantiomeric purity, and demonstrating consistent stereochemical stability during manufacturing and storage. Techniques like chiral HPLC, NMR with chiral solvating agents, and X-ray crystallography are commonly used to assess stereochemistry.
How is stereochemistry controlled in synthesis?
Stereochemistry is controlled through chiral catalysts, chiral auxiliaries, or chiral starting materials in asymmetric synthesis. Processes must be validated to ensure reproducible stereochemical outcomes. Regulatory compliance under ISO 13485, GHS, and REACH requires documentation of stereochemical integrity throughout the product lifecycle. Accurate stereochemical analysis supports safety, efficacy, and quality assurance in active pharmaceutical ingredients (APIs).
Related concepts
Stereochemistry is closely linked to chirality, enantiomeric excess (ee), diastereoselectivity, and absolute configuration. Understanding these concepts is essential for compliance with pharmacopoeial standards such as the British Pharmacopoeia (BP), European Pharmacopoeia (EP), and USP, as well as for ensuring consistent quality in manufacturing processes.